Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD137 deficiency patients: two new patients and review of the literature.

Clinical and experimental immunology·2026
Same author

Human leukocyte antigens in the era of precision medicine in immunology.

Transplant immunology·2026
Same author

Anti-Inflammatory Effect of miR-197-3p-Loaded Microvesicles in Familial Mediterranean Fever Mouse Model.

Cell biochemistry and function·2026
Same author

Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients.

Journal of clinical immunology·2025
Same author

Recurrent eosinophilia with a novel homozygous ARPC1B mutation.

Frontiers of medicine·2024
Same author

Post-transcriptional (re)programming of B lymphocyte development: From bench to bedside?

Advances in immunology·2024
Same journal

Multiple Targeting Routes of MicroRNA-22 Inform Cancer Drug Discovery.

Gene technology·2026
Same journal

Strategies and Best Practice in Cloning Small RNAs.

Gene technology·2020
Same journal

Chromatin Memory in the Development of Human Cancers.

Gene technology·2015
See all related articles

Related Experiment Video

Updated: Dec 9, 2025

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.5K

Genetic Engineering to Induce Fetal-Like Hematopoietic Stem Cells.

Bariş Ulum1, Stefan A Muljo1

  • 1Integrative Immunobiology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland 20892, USA.

Gene Technology
|September 9, 2020
PubMed
Summary
This summary is machine-generated.

Bone marrow transplantation (BMT) faces complications. Researchers propose in utero hematopoietic stem cell transplantation (IUHSCT) using induced fetal-like hematopoietic stem cells (ifHSCs) as a potential alternative for safer cellular therapy.

Keywords:
Cellular EngineeringCellular TherapyHematopoietic Stem CellsPrecision MedicinePrenatal TherapyRNA-binding ProteinsRegenerative Medicine

More Related Videos

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
11:42

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Published on: November 4, 2019

6.3K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.1K

Related Experiment Videos

Last Updated: Dec 9, 2025

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.5K
Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
11:42

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Published on: November 4, 2019

6.3K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.1K

Area of Science:

  • Regenerative Medicine
  • Hematology
  • Developmental Biology

Background:

  • Bone marrow transplantation (BMT) or hematopoietic stem cell transplantation (HSCT) is a foundational cellular therapy.
  • Traditional BMT is associated with significant complications that limit its widespread application.
  • Advances in stem cell technology necessitate exploring alternative therapeutic strategies.

Purpose of the Study:

  • To propose and evaluate in utero hematopoietic stem cell transplantation (IUHSCT) as a novel alternative to traditional BMT.
  • To investigate the potential of induced fetal-like hematopoietic stem cells (ifHSCs) for IUHSCT.
  • To address the limitations and complications associated with current HSCT methods.

Main Methods:

  • Conceptual proposal for IUHSCT utilizing ifHSCs.
  • Review of existing technological advancements in cellular therapy and stem cell induction.
  • Evaluation of the theoretical suitability of ifHSCs for prenatal transplantation.

Main Results:

  • Identification of IUHSCT as a promising alternative to conventional BMT.
  • Hypothesized suitability of ifHSCs for successful in utero engraftment and therapy.
  • Potential to mitigate complications associated with postnatal HSCT.

Conclusions:

  • In utero HSCT (IUHSCT) presents a viable alternative to traditional BMT.
  • Induced fetal-like hematopoietic stem cells (ifHSCs) warrant serious consideration and evaluation for IUHSCT.
  • This approach may offer a safer and more effective cellular therapy strategy.